The effect of netrin-1 on the retinal vascular permeability in early diabetic retinopathy rats
Xianhui Zhou, Xuxia Meng
Abstract
Xianhui Zhou, Xuxia Meng
Abstract
Objective To explore the effect and mechanism of netrin-1 on blood-retinal barrier permeability in diabetes mellitus (DM) rats. Methods Eighty Sprague-Dawley rats were randomly divided into the normal control group, DM+ balanced salt solution (BSS) group, DM+ netrin-1 low dose group and DM+ netrin-1 high dose group, with 20 rats in each group. DM rats were induced by intraperitoneal injection of streptozocin (STZ). These rats were feed with high sugar and fat for 3 months after STZ injection. All rats were sacrificed at 1 month after intravitreal injection. Retinal vascular permeability was measured by Evans blue. The expression level of occludin was determined by immunohistochemistry. Hematoxylin-eosin (HE) staining of retina was used to observe the pathological change of DM and the level of occludin mRNA was analyzed by real-time fluorescence quantitative reverse transcription polymerase chain reaction (RT-PCR). Five rats of each group. Results HE staining of retina showed that the degree of edema and vascularization in DM+ netrin-1 high dose group was better than DM+ BSS group. Staining of occludin in retina was limited to nerve fiber layer, ganglion cells, inner plexiform layer and inner nuclear layer in normal rats, but in DM+ BSS group, the color of staining positive of occludin was lighter and more reduced. However, DM+ netrin-1 group occludin staining was deepen and enlarged. The result of RT-PCR showed that the expression of occludin mRNA in other three groups was less than normal control group (P<0.05). The significant difference during DM+ BSS group, low dose group and DM+ netrin-1 high dose group (F=177.13, P=0.00), and the more concentrate of netrin-1 the higher expression of occluding. Compared the DM+ netrin-1 low dose group with DM+ BSS group, there was significant difference expression of occludin (t=-13.98, P=0.00). There was significant difference between the DM+ netrin-1 high dose group and normal control group (t=12.87, P=0.00). There was statistically significant difference in DM+ BSS group, DM+ netrin-1 low dose group and DM+ netrin-1 high dose group (F=179.69, P=0.00). Compared the two group of different concentration netrin-1, the quantification of vascular permeability in DM+ netrin-1 high dose group reduced more (t=12.73, P=0.00). Conclusions Netrin-1 can protect the blood-retinal barrier in DM rats. Netrin-1 may decrease BRB leakage in DM rats by protecting the expression of occludin. Key words: Diabetic retinopathy/physiopathology; Blood retinal barrier/physiopathology; Nerve growth factors; Animal experimentation
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the effect and mechanism of netrin-1 on blood-retinal barrier permeability in diabetes mellitus (DM) rats. Methods Eighty Sprague-Dawley rats were randomly divided into the normal control group, DM+ balanced salt solution (BSS) group, DM+ netrin-1 low dose group and DM+ netrin-1 high dose group, with 20 rats in each group. DM rats were induced by intraperitoneal injection of streptozocin (STZ). These rats were feed with high sugar and fat for 3 months after STZ injection. All rats were sacrificed at 1 month after intravitreal injection. Retinal vascular permeability was measured by Evans blue. The expression level of occludin was determined by immunohistochemistry. Hematoxylin-eosin (HE) staining of retina was used to observe the pathological change of DM and the level of occludin mRNA was analyzed by real-time fluorescence quantitative reverse transcription polymerase chain reaction (RT-PCR). Five rats of each group. Results HE staining of retina showed that the degree of edema and vascularization in DM+ netrin-1 high dose group was better than DM+ BSS group. Staining of occludin in retina was limited to nerve fiber layer, ganglion cells, inner plexiform layer and inner nuclear layer in normal rats, but in DM+ BSS group, the color of staining positive of occludin was lighter and more reduced. However, DM+ netrin-1 group occludin staining was deepen and enlarged. The result of RT-PCR showed that the expression of occludin mRNA in other three groups was less than normal control group (P<0.05). The significant difference during DM+ BSS group, low dose group and DM+ netrin-1 high dose group (F=177.13, P=0.00), and the more concentrate of netrin-1 the higher expression of occluding. Compared the DM+ netrin-1 low dose group with DM+ BSS group, there was significant difference expression of occludin (t=-13.98, P=0.00). There was significant difference between the DM+ netrin-1 high dose group and normal control group (t=12.87, P=0.00). There was statistically significant difference in DM+ BSS group, DM+ netrin-1 low dose group and DM+ netrin-1 high dose group (F=179.69, P=0.00). Compared the two group of different concentration netrin-1, the quantification of vascular permeability in DM+ netrin-1 high dose group reduced more (t=12.73, P=0.00). Conclusions Netrin-1 can protect the blood-retinal barrier in DM rats. Netrin-1 may decrease BRB leakage in DM rats by protecting the expression of occludin. Key words: Diabetic retinopathy/physiopathology; Blood retinal barrier/physiopathology; Nerve growth factors; Animal experimentation
Key concepts: Occludin, Outer nuclear layer, Retina, Inner nuclear layer, Diabetic retinopathy, Retinal, Blood–retinal barrier, Nerve fiber layer